25.10.2014 Views

Full text PDF - International Policy Network

Full text PDF - International Policy Network

Full text PDF - International Policy Network

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

72 Fighting the Diseases of Poverty<br />

health and education spending and urbanization are controlled for,<br />

but remains significant.<br />

In measuring the impact of corruption on the effectiveness of<br />

health spending Rajkumar and Swaroop (2002) analyze data for<br />

1990 and 1997 controlling for GDP per capita, female educational<br />

attainment, ethno-linguistic fractionalization, urbanization among<br />

other factors, and find that the effectiveness of public health<br />

spending in reducing child mortality hinges on the integrity rating<br />

(1–5 range based on level of perceived corruption), with higher<br />

integrity associated with reduced mortality. Poor governance may<br />

help to explain the inconclusive findings of Filmer and Pritchett<br />

(1999) on the lack of association between public health expenditures<br />

and infant and child mortality.<br />

Wagstaff and Claeson (2005) extend these analyses further and<br />

use more recent data. They find that spending reduces under 5 mortality,<br />

but only where governance, as measured by the World Bank’s<br />

CPIA score (Country <strong>Policy</strong> and Institutional Assessment measure<br />

that is scored between 1–5 depending on performance, part of<br />

which regards corruption and governance), is sound (a CPIA above<br />

3.25). This study specifically explores the implications of additional<br />

spending for reaching the MDGs, and concludes that more spending<br />

in medium and low CPIA countries would not be expected to reduce<br />

child mortality, and that per capita income growth offers a better<br />

investment if mortality declines are the objective.<br />

Because child mortality rates are measured with substantial<br />

error, especially in the poorest countries, these results need to be<br />

taken with caution. The uncertainty of the direction of causality<br />

introduces further limitations in the interpretations of the results.<br />

Cross-country regressions are hard to interpret in any event, but as<br />

an aggregate assessment they provide general guidance on the relevance<br />

of corruption and other factors in affecting health outcomes<br />

in developing countries. The inability of country level analysis to<br />

elucidate specific country problems leads to the subsequent section<br />

that addresses these issues, complementing this introductory look<br />

at the correlates of health outcomes.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!